Key statistics
On Monday, NuCana PLC (NCNA:NAQ) closed at 1.56, 4.00% above its 52-week low of 1.50, set on Nov 08, 2024.
52-week range
Open | 1.50 |
---|---|
High | 1.63 |
Low | 1.50 |
Bid | 1.55 |
Offer | 1.57 |
Previous close | 1.51 |
Average volume | 118.40k |
---|---|
Shares outstanding | 90.66k |
Free float | 67.99k |
P/E (TTM) | -- |
Market cap | 3.41m USD |
EPS (TTM) | -227.74 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 21:00 GMT.
More ▼
- NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
- NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
- NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
- NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
- NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
- NuCana to Present at the Jefferies Global Healthcare Conference
- NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
- NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
- NuCana Announces Completion of ADS Ratio Change
More ▼